Emrosi (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.

A pharmacist explains the similarities and differences between these two antibiotics Minocycline and doxycycline are antibiotics commonly prescribed for various medical conditions. They work by ...

The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in ...

Minocycline 100mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains magnesium sulfate heptahydrate. The tetracyclines are primarily bacteriostatic and are ...

FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for RosaceaEmrosi Initial Distribution Ongoing; First ...

A low-dose (40 mg) modified formulation of minocycline hydrochloride (DFD-29) was better tolerated and more effective than doxycycline and placebo in patients with moderate to severe ...

Recent network meta-analyses identified the relative outcomes of various vitiligo monotherapies on vitiligo at 6 months.

An increasing amount of evidence suggests that the FDA-approved antibiotic minocycline might have neuroprotective effects in animal models of various neurodegenerative disorders, and Gordon et al.